Press Release: INTELLIA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Intellia Therapeutics, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Intellia Therapeutics, Inc. (“Intellia” or the “Company”) (NASDAQ:NTLA) in the United States District Court for the District of Massachusetts on behalf of all persons and…
Press Release: INTELLIA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Intellia Therapeutics, Inc. and Encourages Investors to Contact the Firm - Newscast
Wed, 07 May 2025 08:02:00 GMT Analysts expect Intellia Therapeutics to report an earnings per share (EPS) of $-1.27. Anticipation surrounds Intellia Therapeutics's announcement, with investors hoping to hear about both surpassing ...
Mon, 14 Apr 2025 05:15:00 GMT The truth emerged on January 9, 2025, when Intellia published a press release announcing Company reorganization. In pertinent part, defendants disclosed that Intellia would be halting all NTLA ...
Sun, 13 Apr 2025 05:59:00 GMT The truth emerged on January 9, 2025, when Intellia published a press release announcing Company reorganization. In pertinent part, defendants disclosed that Intellia would be halting all NTLA ...
Sat, 12 Apr 2025 00:18:00 GMT On January 9, 2025, Intellia issued a press release "announc[ing] its strategic priorities and key anticipated 2025 milestones". Among other items, Intellia announced that it plans to focus its ...
